Thompson Investment Management Inc. Acquires 10,534 Shares of CVS Health Co. (NYSE:CVS)

Thompson Investment Management Inc. grew its position in CVS Health Co. (NYSE:CVS) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 145,783 shares of the pharmacy operator’s stock after purchasing an additional 10,534 shares during the quarter. Thompson Investment Management Inc.’s holdings in CVS Health were worth $6,544,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the 3rd quarter valued at $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health during the third quarter worth $31,000. Reston Wealth Management LLC acquired a new position in CVS Health during the third quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the third quarter worth $33,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

Shares of CVS stock opened at $53.95 on Friday. The company’s fifty day moving average price is $50.79 and its 200-day moving average price is $56.01. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock has a market cap of $67.90 billion, a PE ratio of 13.69, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.21 EPS. On average, equities analysts expect that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.93%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Royal Bank of Canada lowered their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Truist Financial decreased their price target on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $68.12.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.